LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 31.62 | 84.90 | 744 | 2449 | 0.3037 | 0.5644 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 31.62 | 84.90 | 955 | 2449 | 0.3898 | 0.6470 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 33.32 | 84.90 | 1024 | 2722 | 0.3761 | 0.6449 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 33.32 | 84.90 | 1074 | 2722 | 0.3945 | 0.6607 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 33.32 | 84.90 | 757 | 2722 | 0.2781 | 0.5486 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 33.32 | 84.90 | 929 | 2722 | 0.3412 | 0.6132 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 35.03 | 84.90 | 1045 | 2991 | 0.3494 | 0.6299 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 35.03 | 84.90 | 1082 | 2991 | 0.3617 | 0.6409 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 35.03 | 84.90 | 785 | 2991 | 0.2624 | 0.5416 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 35.03 | 84.90 | 950 | 2991 | 0.3176 | 0.5999 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 36.73 | 84.90 | 1077 | 3254 | 0.3310 | 0.6208 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 36.73 | 84.90 | 1114 | 3254 | 0.3423 | 0.6313 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 36.73 | 84.90 | 902 | 3254 | 0.2772 | 0.5671 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 36.73 | 84.90 | 975 | 3254 | 0.2996 | 0.5905 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 38.43 | 84.90 | 1119 | 3459 | 0.3234 | 0.6195 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 38.43 | 84.90 | 1156 | 3459 | 0.3341 | 0.6294 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 38.43 | 84.90 | 876 | 3459 | 0.2532 | 0.5471 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 38.43 | 84.90 | 925 | 3459 | 0.2674 | 0.5629 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 40.14 | 84.90 | 1110 | 3682 | 0.3015 | 0.6043 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 40.14 | 84.90 | 1146 | 3682 | 0.3112 | 0.6137 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 40.14 | 84.90 | 879 | 3682 | 0.2387 | 0.5369 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 40.14 | 84.90 | 941 | 3682 | 0.2556 | 0.5563 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 41.84 | 84.90 | 1105 | 4003 | 0.2760 | 0.5866 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 41.84 | 84.90 | 1139 | 4003 | 0.2845 | 0.5953 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 41.84 | 84.90 | 896 | 4003 | 0.2238 | 0.5279 | MN20160318_Q02 | F10 |